Question special

I thought it was very interesting that you found a significantly lower likelihood of COVID-19 positivity in patients on beta-blockers for any indication. You mentioned in your discussion this could be related to beta blocker effects on the RAAS system. Any thoughts on the biological plausibility of BB being significantly different from ACEi/ARBs? Second, do you think it is more likely this finding is from a confounding variable?